This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neurofibromatosis 1 (NF1), a genetic syndrome with a prevalence of 1/1,000–1/3,500 people, predisposes to intellectual disability, social–behavioral and learning problems, and tumors. Although the NF gene was identified in 1990, genotypic–phenotypic correlations have proven elusive. Known correlations include deletion of the entire NF1 gene (severe phenotype), missense mutations (spinal neurofibromatosis) and exon 17 base pair in-frame deletion c.2970-2972 (mild phenotype), and clustering of mutations in the 5′-end in patients with optic pathway gliomas.1 Clinicians and researchers alike would benefit from better mutation predictors of clinical outcomes, not only for streamlining appropriate surveillance and intervention, but to direct research, both tumoral and cognitive.
Footnotes
Comment: 377
Study funding: No targeted funding reported.
Disclosure: Dr. Campen and Dr. Greenwood report no disclosures. Go to Neurology.org/N for full disclosures.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use
Eliminating barriers to personalized medicine
A genotype–phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1
Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus